Global Meloxicam Market Research Report 2020

Global Meloxicam Market Research Report 2020

Table of Contents
1 Meloxicam Market Overview
1.1 Product Overview and Scope of Meloxicam
1.2 Meloxicam Segment by Ingredient
1.2.1 Global Meloxicam Sales Growth Rate Comparison by Ingredient (2021-2026)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Meloxicam Segment by Application
1.3.1 Meloxicam Sales Comparison by Application: 2020 VS 2026
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Soft Tissue Inflammation
1.3.5 Traumatic Pain
1.3.6 Post-Operative Pain
1.3.7 Other
1.4 Global Meloxicam Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Revenue 2015-2026
1.4.2 Global Meloxicam Sales 2015-2026
1.4.3 Meloxicam Market Size by Region: 2020 Versus 2026
2 Global Meloxicam Market Competition by Manufacturers
2.1 Global Meloxicam Sales Market Share by Manufacturers (2015-2020)
2.2 Global Meloxicam Revenue Share by Manufacturers (2015-2020)
2.3 Global Meloxicam Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Meloxicam Manufacturing Sites, Area Served, Product Type
2.5 Meloxicam Market Competitive Situation and Trends
2.5.1 Meloxicam Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Meloxicam Players (Opinion Leaders)
3 Meloxicam Retrospective Market Scenario by Region
3.1 Global Meloxicam Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Meloxicam Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Meloxicam Market Facts & Figures by Country
3.3.1 North America Meloxicam Sales by Country
3.3.2 North America Meloxicam Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meloxicam Market Facts & Figures by Country
3.4.1 Europe Meloxicam Sales by Country
3.4.2 Europe Meloxicam Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meloxicam Market Facts & Figures by Region
3.5.1 Asia Pacific Meloxicam Sales by Region
3.5.2 Asia Pacific Meloxicam Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meloxicam Market Facts & Figures by Country
3.6.1 Latin America Meloxicam Sales by Country
3.6.2 Latin America Meloxicam Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Meloxicam Market Facts & Figures by Country
3.7.1 Middle East and Africa Meloxicam Sales by Country
3.7.2 Middle East and Africa Meloxicam Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meloxicam Historic Market Analysis by Type
4.1 Global Meloxicam Sales Market Share by Type (2015-2020)
4.2 Global Meloxicam Revenue Market Share by Type (2015-2020)
4.3 Global Meloxicam Price Market Share by Type (2015-2020)
4.4 Global Meloxicam Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Meloxicam Historic Market Analysis by Application
5.1 Global Meloxicam Sales Market Share by Application (2015-2020)
5.2 Global Meloxicam Revenue Market Share by Application (2015-2020)
5.3 Global Meloxicam Price by Application (2015-2020)
6 Company Profiles and Key Figures in Meloxicam Business
6.1 Boehringer Ingelheim
6.1.1 Corporation Information
6.1.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Boehringer Ingelheim Products Offered
6.1.5 Boehringer Ingelheim Recent Development
6.2 Baudax
6.2.1 Baudax Meloxicam Production Sites and Area Served
6.2.2 Baudax Description, Business Overview and Total Revenue
6.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Baudax Products Offered
6.2.5 Baudax Recent Development
6.3 Perrigo
6.3.1 Perrigo Meloxicam Production Sites and Area Served
6.3.2 Perrigo Description, Business Overview and Total Revenue
6.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Perrigo Products Offered
6.3.5 Perrigo Recent Development
6.4 Recro Pharma
6.4.1 Recro Pharma Meloxicam Production Sites and Area Served
6.4.2 Recro Pharma Description, Business Overview and Total Revenue
6.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Recro Pharma Products Offered
6.4.5 Recro Pharma Recent Development
6.5 Iroko Pharma
6.5.1 Iroko Pharma Meloxicam Production Sites and Area Served
6.5.2 Iroko Pharma Description, Business Overview and Total Revenue
6.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Iroko Pharma Products Offered
6.5.5 Iroko Pharma Recent Development
6.6 Zyla Life Sciences
6.6.1 Zyla Life Sciences Meloxicam Production Sites and Area Served
6.6.2 Zyla Life Sciences Description, Business Overview and Total Revenue
6.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Zyla Life Sciences Products Offered
6.6.5 Zyla Life Sciences Recent Development
6.7 Axsome Therapeutics
6.6.1 Axsome Therapeutics Meloxicam Production Sites and Area Served
6.6.2 Axsome Therapeutics Description, Business Overview and Total Revenue
6.6.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Axsome Therapeutics Products Offered
6.7.5 Axsome Therapeutics Recent Development
6.8 Orbis Biosciences
6.8.1 Orbis Biosciences Meloxicam Production Sites and Area Served
6.8.2 Orbis Biosciences Description, Business Overview and Total Revenue
6.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Orbis Biosciences Products Offered
6.8.5 Orbis Biosciences Recent Development
6.9 Cellix Bio
6.9.1 Cellix Bio Meloxicam Production Sites and Area Served
6.9.2 Cellix Bio Description, Business Overview and Total Revenue
6.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Cellix Bio Products Offered
6.9.5 Cellix Bio Recent Development
6.10 Ligand Pharma
6.10.1 Ligand Pharma Meloxicam Production Sites and Area Served
6.10.2 Ligand Pharma Description, Business Overview and Total Revenue
6.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Ligand Pharma Products Offered
6.10.5 Ligand Pharma Recent Development
6.11 SEDOR Pharma
6.11.1 SEDOR Pharma Meloxicam Production Sites and Area Served
6.11.2 SEDOR Pharma Meloxicam Description, Business Overview and Total Revenue
6.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.11.4 SEDOR Pharma Products Offered
6.11.5 SEDOR Pharma Recent Development
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Meloxicam Production Sites and Area Served
6.12.2 Heron Therapeutics Meloxicam Description, Business Overview and Total Revenue
6.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Heron Therapeutics Products Offered
6.12.5 Heron Therapeutics Recent Development
6.13 Pacira BioSciences
6.13.1 Pacira BioSciences Meloxicam Production Sites and Area Served
6.13.2 Pacira BioSciences Meloxicam Description, Business Overview and Total Revenue
6.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Pacira BioSciences Products Offered
6.13.5 Pacira BioSciences Recent Development
6.14 Sanofi
6.14.1 Sanofi Meloxicam Production Sites and Area Served
6.14.2 Sanofi Meloxicam Description, Business Overview and Total Revenue
6.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Sanofi Products Offered
6.14.5 Sanofi Recent Development
6.15 Eurofarma Laboratorio
6.15.1 Eurofarma Laboratorio Meloxicam Production Sites and Area Served
6.15.2 Eurofarma Laboratorio Meloxicam Description, Business Overview and Total Revenue
6.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Eurofarma Laboratorio Products Offered
6.15.5 Eurofarma Laboratorio Recent Development
6.16 TerSera Therapeutics
6.16.1 TerSera Therapeutics Meloxicam Production Sites and Area Served
6.16.2 TerSera Therapeutics Meloxicam Description, Business Overview and Total Revenue
6.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.16.4 TerSera Therapeutics Products Offered
6.16.5 TerSera Therapeutics Recent Development
6.17 Apotex
6.17.1 Apotex Meloxicam Production Sites and Area Served
6.17.2 Apotex Meloxicam Description, Business Overview and Total Revenue
6.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Apotex Products Offered
6.17.5 Apotex Recent Development
6.18 Yung Shin Pharmaceutical
6.18.1 Yung Shin Pharmaceutical Meloxicam Production Sites and Area Served
6.18.2 Yung Shin Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Yung Shin Pharmaceutical Products Offered
6.18.5 Yung Shin Pharmaceutical Recent Development
6.19 Breckenridge Pharmaceutical
6.19.1 Breckenridge Pharmaceutical Meloxicam Production Sites and Area Served
6.19.2 Breckenridge Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Breckenridge Pharmaceutical Products Offered
6.19.5 Breckenridge Pharmaceutical Recent Development
6.20 Zydus Pharmaceuticals
6.20.1 Zydus Pharmaceuticals Meloxicam Production Sites and Area Served
6.20.2 Zydus Pharmaceuticals Meloxicam Description, Business Overview and Total Revenue
6.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Zydus Pharmaceuticals Products Offered
6.20.5 Zydus Pharmaceuticals Recent Development
6.21 Unichem Pharmaceuticals
6.21.1 Unichem Pharmaceuticals Meloxicam Production Sites and Area Served
6.21.2 Unichem Pharmaceuticals Meloxicam Description, Business Overview and Total Revenue
6.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Unichem Pharmaceuticals Products Offered
6.21.5 Unichem Pharmaceuticals Recent Development
6.22 Strides Pharma
6.22.1 Strides Pharma Meloxicam Production Sites and Area Served
6.22.2 Strides Pharma Meloxicam Description, Business Overview and Total Revenue
6.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Strides Pharma Products Offered
6.22.5 Strides Pharma Recent Development
6.23 Cipla
6.23.1 Cipla Meloxicam Production Sites and Area Served
6.23.2 Cipla Meloxicam Description, Business Overview and Total Revenue
6.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.23.4 Cipla Products Offered
6.23.5 Cipla Recent Development
6.24 Dr. Reddy's Laboratories
6.24.1 Dr. Reddy's Laboratories Meloxicam Production Sites and Area Served
6.24.2 Dr. Reddy's Laboratories Meloxicam Description, Business Overview and Total Revenue
6.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.24.4 Dr. Reddy's Laboratories Products Offered
6.24.5 Dr. Reddy's Laboratories Recent Development
6.25 Glenmark Pharmaceuticals
6.25.1 Glenmark Pharmaceuticals Meloxicam Production Sites and Area Served
6.25.2 Glenmark Pharmaceuticals Meloxicam Description, Business Overview and Total Revenue
6.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.25.4 Glenmark Pharmaceuticals Products Offered
6.25.5 Glenmark Pharmaceuticals Recent Development
6.26 Teva
6.26.1 Teva Meloxicam Production Sites and Area Served
6.26.2 Teva Meloxicam Description, Business Overview and Total Revenue
6.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.26.4 Teva Products Offered
6.26.5 Teva Recent Development
6.27 PuraCap Pharmaceutical
6.27.1 PuraCap Pharmaceutical Meloxicam Production Sites and Area Served
6.27.2 PuraCap Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.27.4 PuraCap Pharmaceutical Products Offered
6.27.5 PuraCap Pharmaceutical Recent Development
6.28 TARO
6.28.1 TARO Meloxicam Production Sites and Area Served
6.28.2 TARO Meloxicam Description, Business Overview and Total Revenue
6.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.28.4 TARO Products Offered
6.28.5 TARO Recent Development
6.29 Lupin Pharmaceuticals
6.29.1 Lupin Pharmaceuticals Meloxicam Production Sites and Area Served
6.29.2 Lupin Pharmaceuticals Meloxicam Description, Business Overview and Total Revenue
6.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.29.4 Lupin Pharmaceuticals Products Offered
6.29.5 Lupin Pharmaceuticals Recent Development
6.30 Aurobindo Pharma
6.30.1 Aurobindo Pharma Meloxicam Production Sites and Area Served
6.30.2 Aurobindo Pharma Meloxicam Description, Business Overview and Total Revenue
6.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.30.4 Aurobindo Pharma Products Offered
6.30.5 Aurobindo Pharma Recent Development
6.31 Shanghai Bolinger Ingelheim Pharmaceutical
6.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Production Sites and Area Served
6.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Products Offered
6.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Development
6.32 Shanghai Zhaohui Pharmaceutical
6.32.1 Shanghai Zhaohui Pharmaceutical Meloxicam Production Sites and Area Served
6.32.2 Shanghai Zhaohui Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.32.4 Shanghai Zhaohui Pharmaceutical Products Offered
6.32.5 Shanghai Zhaohui Pharmaceutical Recent Development
6.33 Sichuan Shenghe Pharmaceutical
6.33.1 Sichuan Shenghe Pharmaceutical Meloxicam Production Sites and Area Served
6.33.2 Sichuan Shenghe Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.33.4 Sichuan Shenghe Pharmaceutical Products Offered
6.33.5 Sichuan Shenghe Pharmaceutical Recent Development
6.34 Ningxia Kangya Pharmaceutical
6.34.1 Ningxia Kangya Pharmaceutical Meloxicam Production Sites and Area Served
6.34.2 Ningxia Kangya Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.34.4 Ningxia Kangya Pharmaceutical Products Offered
6.34.5 Ningxia Kangya Pharmaceutical Recent Development
6.35 Yangtze Pharmaceutical Group
6.35.1 Yangtze Pharmaceutical Group Meloxicam Production Sites and Area Served
6.35.2 Yangtze Pharmaceutical Group Meloxicam Description, Business Overview and Total Revenue
6.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.35.4 Yangtze Pharmaceutical Group Products Offered
6.35.5 Yangtze Pharmaceutical Group Recent Development
6.36 Kunshan Longdeng Ruidi Pharmaceutical
6.36.1 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Production Sites and Area Served
6.36.2 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.36.4 Kunshan Longdeng Ruidi Pharmaceutical Products Offered
6.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Development
6.37 Jiangsu Yabang Epson Pharmaceutical
6.37.1 Jiangsu Yabang Epson Pharmaceutical Meloxicam Production Sites and Area Served
6.37.2 Jiangsu Yabang Epson Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.37.4 Jiangsu Yabang Epson Pharmaceutical Products Offered
6.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Development
6.38 Jiangsu Feima Pharmaceutical Co. , Ltd
6.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Production Sites and Area Served
6.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Description, Business Overview and Total Revenue
6.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Products Offered
6.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Development
6.39 Zhejiang Xianju Pharmaceutical
6.39.1 Zhejiang Xianju Pharmaceutical Meloxicam Production Sites and Area Served
6.39.2 Zhejiang Xianju Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.39.4 Zhejiang Xianju Pharmaceutical Products Offered
6.39.5 Zhejiang Xianju Pharmaceutical Recent Development
6.40 Hainan All Star Pharmaceutical
6.40.1 Hainan All Star Pharmaceutical Meloxicam Production Sites and Area Served
6.40.2 Hainan All Star Pharmaceutical Meloxicam Description, Business Overview and Total Revenue
6.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2015-2020)
6.40.4 Hainan All Star Pharmaceutical Products Offered
6.40.5 Hainan All Star Pharmaceutical Recent Development
6.41 Hainan Aomeihua Pharmaceutical
6.42 Hunan Mingrui Pharmaceutical
6.43 Suzhou Sinochem Pharmaceutical
6.44 Qilu Pharmaceutical
6.45 Sichuan Luye Pharmaceutical
6.46 Shandong Xinhua Pharmaceutical
6.47 Guangdong Renkang Pharmaceutical
6.48 Hainan Selike Pharmaceutical
7 Meloxicam Manufacturing Cost Analysis
7.1 Meloxicam Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meloxicam
7.4 Meloxicam Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meloxicam Distributors List
8.3 Meloxicam Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Meloxicam Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meloxicam by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Meloxicam by Type (2021-2026)
10.2 Meloxicam Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meloxicam by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Meloxicam by Application (2021-2026)
10.3 Meloxicam Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meloxicam by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Meloxicam by Region (2021-2026)
10.4 North America Meloxicam Estimates and Projections (2021-2026)
10.5 Europe Meloxicam Estimates and Projections (2021-2026)
10.6 Asia Pacific Meloxicam Estimates and Projections (2021-2026)
10.7 Latin America Meloxicam Estimates and Projections (2021-2026)
10.8 Middle East and Africa Meloxicam Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Meloxicam Sales (KG) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Meloxicam Sales (KG) Comparison by Application: 2020 VS 2026
Table 3. Global Meloxicam Market Size by Type (KG) (US$ Million) (2020 VS 2026)
Table 4. Global Key Meloxicam Manufacturers Covered in This Study
Table 5. Global Meloxicam Sales (KG) by Manufacturers (2015-2020)
Table 6. Global Meloxicam Sales Share by Manufacturers (2015-2020)
Table 7. Global Meloxicam Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Meloxicam Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Meloxicam Average Price (US$/G) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Meloxicam Sales Sites and Area Served
Table 11. Manufacturers Meloxicam Product Types
Table 12. Global Meloxicam Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meloxicam by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Meloxicam Players
Table 16. Global Meloxicam Sales (KG) by Region (2015-2020)
Table 17. Global Meloxicam Sales Market Share by Region (2015-2020)
Table 18. Global Meloxicam Revenue (Million US$) by Region (2015-2020)
Table 19. Global Meloxicam Revenue Market Share by Region (2015-2020)
Table 20. North America Meloxicam Sales by Country (2015-2020) (KG)
Table 21. North America Meloxicam Sales Market Share by Country (2015-2020)
Table 22. North America Meloxicam Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Meloxicam Revenue Market Share by Country (2015-2020)
Table 24. Europe Meloxicam Sales by Country (2015-2020) (KG)
Table 25. Europe Meloxicam Sales Market Share by Country (2015-2020)
Table 26. Europe Meloxicam Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Meloxicam Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Meloxicam Sales by Region (2015-2020) (KG)
Table 29. Asia Pacific Meloxicam Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Meloxicam Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Meloxicam Revenue Market Share by Region (2015-2020)
Table 32. Latin America Meloxicam Sales by Country (2015-2020) (KG)
Table 33. Latin America Meloxicam Sales Market Share by Country (2015-2020)
Table 34. Latin America Meloxicam Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Meloxicam Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Meloxicam Sales by Country (2015-2020) (KG)
Table 37. Middle East and Africa Meloxicam Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Meloxicam Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Meloxicam Revenue Market Share by Country (2015-2020)
Table 40. Global Meloxicam Sales (KG) by Type (2015-2020)
Table 41. Global Meloxicam Sales Share by Type (2015-2020)
Table 42. Global Meloxicam Revenue (Million US$) by Type (2015-2020)
Table 43. Global Meloxicam Revenue Share by Type (2015-2020)
Table 44. Global Meloxicam Price (US$/G) by Type (2015-2020)
Table 45. Global Meloxicam Sales (KG) by Application (2015-2020)
Table 46. Global Meloxicam Sales Market Share by Application (2015-2020)
Table 47. Global Meloxicam Sales Growth Rate by Application (2015-2020)
Table 48. Boehringer Ingelheim Meloxicam Corporation Information
Table 49. Boehringer Ingelheim Description and Business Overview
Table 50. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 51. Boehringer Ingelheim Main Product
Table 52. Boehringer Ingelheim Recent Development
Table 53. Baudax Meloxicam Corporation Information
Table 54. Baudax Corporation Information
Table 55. Baudax Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 56. Baudax Main Product
Table 57. Baudax Recent Development
Table 58. Perrigo Meloxicam Corporation Information
Table 59. Perrigo Corporation Information
Table 60. Perrigo Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 61. Perrigo Main Product
Table 62. Perrigo Recent Development
Table 63. Recro Pharma Meloxicam Corporation Information
Table 64. Recro Pharma Corporation Information
Table 65. Recro Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 66. Recro Pharma Main Product
Table 67. Recro Pharma Recent Development
Table 68. Iroko Pharma Meloxicam Corporation Information
Table 69. Iroko Pharma Corporation Information
Table 70. Iroko Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 71. Iroko Pharma Main Product
Table 72. Iroko Pharma Recent Development
Table 73. Zyla Life Sciences Meloxicam Corporation Information
Table 74. Zyla Life Sciences Corporation Information
Table 75. Zyla Life Sciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 76. Zyla Life Sciences Main Product
Table 77. Zyla Life Sciences Recent Development
Table 78. Axsome Therapeutics Meloxicam Corporation Information
Table 79. Axsome Therapeutics Corporation Information
Table 80. Axsome Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 81. Axsome Therapeutics Main Product
Table 82. Axsome Therapeutics Recent Development
Table 83. Orbis Biosciences Meloxicam Corporation Information
Table 84. Orbis Biosciences Corporation Information
Table 85. Orbis Biosciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 86. Orbis Biosciences Main Product
Table 87. Orbis Biosciences Recent Development
Table 88. Cellix Bio Meloxicam Corporation Information
Table 89. Cellix Bio Corporation Information
Table 90. Cellix Bio Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 91. Cellix Bio Main Product
Table 92. Cellix Bio Recent Development
Table 93. Ligand Pharma Meloxicam Corporation Information
Table 94. Ligand Pharma Corporation Information
Table 95. Ligand Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 96. Ligand Pharma Main Product
Table 97. Ligand Pharma Recent Development
Table 98. SEDOR Pharma Meloxicam Corporation Information
Table 99. SEDOR Pharma Corporation Information
Table 100. SEDOR Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 101. SEDOR Pharma Main Product
Table 102. SEDOR Pharma Recent Development
Table 103. Heron Therapeutics Meloxicam Corporation Information
Table 104. Heron Therapeutics Corporation Information
Table 105. Heron Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 106. Heron Therapeutics Main Product
Table 107. Heron Therapeutics Recent Development
Table 108. Pacira BioSciences Meloxicam Corporation Information
Table 109. Pacira BioSciences Corporation Information
Table 110. Pacira BioSciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 111. Pacira BioSciences Main Product
Table 112. Pacira BioSciences Recent Development
Table 113. Sanofi Meloxicam Corporation Information
Table 114. Sanofi Corporation Information
Table 115. Sanofi Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 116. Sanofi Main Product
Table 117. Sanofi Recent Development
Table 118. Eurofarma Laboratorio Meloxicam Corporation Information
Table 119. Eurofarma Laboratorio Corporation Information
Table 120. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 121. Eurofarma Laboratorio Main Product
Table 122. Eurofarma Laboratorio Recent Development
Table 123. TerSera Therapeutics Meloxicam Corporation Information
Table 124. TerSera Therapeutics Corporation Information
Table 125. TerSera Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 126. TerSera Therapeutics Main Product
Table 127. TerSera Therapeutics Recent Development
Table 128. Apotex Meloxicam Corporation Information
Table 129. Apotex Corporation Information
Table 130. Apotex Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 131. Apotex Main Product
Table 132. Apotex Recent Development
Table 133. Yung Shin Pharmaceutical Meloxicam Corporation Information
Table 134. Yung Shin Pharmaceutical Corporation Information
Table 135. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 136. Yung Shin Pharmaceutical Main Product
Table 137. Yung Shin Pharmaceutical Recent Development
Table 138. Breckenridge Pharmaceutical Meloxicam Corporation Information
Table 139. Breckenridge Pharmaceutical Corporation Information
Table 140. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 141. Breckenridge Pharmaceutical Main Product
Table 142. Breckenridge Pharmaceutical Recent Development
Table 143. Zydus Pharmaceuticals Meloxicam Corporation Information
Table 144. Zydus Pharmaceuticals Corporation Information
Table 145. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 146. Zydus Pharmaceuticals Main Product
Table 147. Zydus Pharmaceuticals Recent Development
Table 148. Unichem Pharmaceuticals Meloxicam Corporation Information
Table 149. Unichem Pharmaceuticals Corporation Information
Table 150. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 151. Unichem Pharmaceuticals Main Product
Table 152. Unichem Pharmaceuticals Recent Development
Table 153. Strides Pharma Meloxicam Corporation Information
Table 154. Strides Pharma Corporation Information
Table 155. Strides Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 156. Strides Pharma Main Product
Table 157. Strides Pharma Recent Development
Table 158. Cipla Meloxicam Corporation Information
Table 159. Cipla Corporation Information
Table 160. Cipla Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 161. Cipla Main Product
Table 162. Cipla Recent Development
Table 163. Dr. Reddy's Laboratories Meloxicam Corporation Information
Table 164. Dr. Reddy's Laboratories Corporation Information
Table 165. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 166. Dr. Reddy's Laboratories Main Product
Table 167. Dr. Reddy's Laboratories Recent Development
Table 168. Glenmark Pharmaceuticals Meloxicam Corporation Information
Table 169. Glenmark Pharmaceuticals Corporation Information
Table 170. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 171. Glenmark Pharmaceuticals Main Product
Table 172. Glenmark Pharmaceuticals Recent Development
Table 173. Teva Meloxicam Corporation Information
Table 174. Teva Corporation Information
Table 175. Teva Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 176. Teva Main Product
Table 177. Teva Recent Development
Table 178. PuraCap Pharmaceutical Meloxicam Corporation Information
Table 179. PuraCap Pharmaceutical Corporation Information
Table 180. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 181. PuraCap Pharmaceutical Main Product
Table 182. PuraCap Pharmaceutical Recent Development
Table 183. TARO Meloxicam Corporation Information
Table 184. TARO Corporation Information
Table 185. TARO Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 186. TARO Main Product
Table 187. TARO Recent Development
Table 188. Lupin Pharmaceuticals Meloxicam Corporation Information
Table 189. Lupin Pharmaceuticals Corporation Information
Table 190. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2015-2020)
Table 191. Lupin Pharmaceuticals Main Product
Table 192. Lupin Pharmaceuticals Recent Development
Table 193. Aurobindo Pharma Meloxicam Corporation Information
Table 194. Aurobindo Pharma Corporation Information
Table 195. Aurobindo Pharma Meloxicam Sales (KG), Revenu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs